The candidate vaccine for the coronavirus disease 2019 (Covid-19) that the private sector funded for acquisition from AstreZeneca will still need local regulatory approval before it could be used to inoculate at least 1.2 million Filipinos.
Speaking at the Laging Handa public briefing on Saturday, Department of Health Undersecretary (DOH) Maria Rosario Vergeire said the vaccine of AstraZeneca will not be used in the country if it fails to get approval from the joint panel composed of the DoH, Department of Science and Technology and the Food and Drug Administration (FDA).
“Hindi natin papayagan sa ating merkado kung sakaling walang rehistro from the FDA (We will not allow that vaccine to enter the market if in case it does not have registration from the FDA),” she said.
Vergeire added that any Covid-19 vaccine that will enter the country, either through government or government-private sector partnership, must secure the proper approvals from government.
AstraZenec is under fire for previously claiming its vaccine was 90-percent effective and then admitted an error on the data for the tests.On Friday, the government and the private sector signed an agreement with AstraZeneca for the purchase of at least 2.6 million doses of its Covid-10 vaccine that the 30 major Filipino companies providing the funds. The deal is worth P626 million. SOVEREIGNPH